Robert Wild
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Phytochemical compounds biological activities
- Angiogenesis and VEGF in Cancer
- DNA Repair Mechanisms
- Metabolism, Diabetes, and Cancer
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- PI3K/AKT/mTOR signaling in cancer 5
- Phytochemical compounds biological activities 4
- RNA modifications and cancer 3
-
- Cancer, Hypoxia, and Metabolism 14
- Co-authors
- Sundaram Ramakrishnan (5 shared papers)Manju Hingorani (1 shared paper)Edward H. Egelman (1 shared paper)X. Yu (1 shared paper)Smita S. Patel (1 shared paper)A. Douglas Kinghorn (6 shared papers)Arjan W. Griffioen (1 shared paper)Steven M. Swanson (4 shared papers)
- Journals
- Cancer Research (9 papers)Molecular Cancer Therapeutics (4 papers)Journal of Natural Products (3 papers)Clinical Cancer Research (2 papers)npj Precision Oncology (1 paper)
- Partner nations
- United StatesGermanyIndonesia
In The Last Decade
Robert Wild
39 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 382
- Molecular Biology 1.3k
- Toxicology 46
- Oncology 339
- Biochemistry 67
Countries citing papers authored by Robert Wild
This map shows the geographic impact of Robert Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wild more than expected).
Fields of papers citing papers by Robert Wild
This network shows the impact of papers produced by Robert Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wild. The network helps show where Robert Wild may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 243 | |
| 2 | 1995 | 232 | |
| 3 | 2010 | 186 | |
| 4 | 2004 | 170 | |
| 5 | 2011 | 166 | |
| 6 | 2003 | 146 | |
| 7 | 1999 | 128 | |
| 8 | 2000 | 122 | |
| 9 | Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7. | 2007 | 87 |
| 10 | 2023 | 76 | |
| 11 | 2003 | 71 | |
| 12 | Lipids from Lipomyces starkeyi | 2010 | 56 |
| 13 | 2004 | 49 | |
| 14 | 2022 | 48 | |
| 15 | 2008 | 44 | |
| 16 | 2011 | 44 | |
| 17 | 2000 | 38 | |
| 18 | 2007 | 24 | |
| 19 | 2004 | 17 | |
| 20 | 2023 | 13 |
About Robert Wild
Robert Wild is a scholar working on Molecular Biology, Cancer Research, Biotechnology, Oncology and Immunology, having authored 43 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (14 papers), Angiogenesis and VEGF in Cancer (7 papers), Cancer Research and Treatments (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Phytochemical compounds biological activities (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), RNA modifications and cancer (3 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (382 citations), Molecular Biology (1.3k citations), Toxicology (46 citations), Oncology (339 citations) and Biochemistry (67 citations). Robert Wild has collaborated with scholars based in United States, Germany and Indonesia. Frequent co-authors include Sundaram Ramakrishnan, Manju Hingorani, Edward H. Egelman, X. Yu, Smita S. Patel, A. Douglas Kinghorn, Arjan W. Griffioen, Steven M. Swanson, Subramanian Ramakrishnan and Prafulla C. Gokhale. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Natural Products, Clinical Cancer Research and npj Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.